Articles Tagged With: COVID-19
-
Does Semaglutide Protect Against Adverse Effects from COVID-19?
Semaglutide recipients who developed COVID-19 had significant protection against the occurrence of adverse outcomes, including death.
-
Metformin Reduces SARS-CoV-2 Viral Load in Outpatients with COVID-19
A randomized, placebo-controlled clinical trial of outpatients with COVID-19 found that metformin reduced SARS-CoV-2 viral load 3.6-fold compared to placebo, while ivermectin and fluvoxamine showed no benefit.
-
Enlargement of Choroid Plexus in Subacute COVID-19 Patients
The choroid plexus is a network of capillaries whose main role involves facilitating cerebrospinal fluid production and the exchange of nutrients and waste products between the central nervous system and the bloodstream. Immune cells are present near the choroid plexus. Enlargement of the choroid plexus has been noted in patients with multiple sclerosis.
-
Infectious Disease Alert Updates
Abandoning Universal COVID Admission Screening; Does Obesity Affect HIV Drug Levels? Eat Your Fruits and Vegetables!
-
Enlargement of Choroid Plexus in Subacute COVID-19 Patients
The authors of this study hypothesized that there likely is enlargement of the choroid plexus in patients with COVID-19 infections.
-
Age Is Not a Risk Factor for the Oldest Patients with COVID-19
Are patients hospitalized for COVID-19, who are younger than 65 years of age, at less risk of serious outcomes than are similar patients who are older than 85 years of age? New research provides an answer that may surprise many clinicians: Metabolic syndrome measures are a major predictor of outcomes, but chronological age is not a relevant risk factor for poor outcomes attributed to COVID-19.
-
Nirmatrelvir-Ritonavir in High-Risk Vaccinated and Low-Risk Unvaccinated Participants: The EPIC-SR Trial
In this Phase II-III randomized controlled clinical trial (EPIC-SR), nirmatrelvir-ritonavir was not associated with a significant difference in time to alleviation of symptoms nor COVID-19-related hospitalization or death from any cause as compared with placebo in unvaccinated individuals without risk factors for severe disease or in vaccinated individuals with a least one risk factor for severe disease.
-
High-Mortality Cryptococcosis Infection After COVID-19
A survey initiated by the Mycoses Study Group identified 69 cases of cryptococcosis following COVID-19 infection. The mortality rate was 59%, with cases in both immunocompromised and immunocompetent individuals.
-
Is Measles Elimination Status at Risk? Antivaxers Attack MMR Vaccine
As the number of measles cases in the United States already has outstripped total cases for last year, employee health professionals should prepare for incoming cases that can wreak havoc in a hospital if undetected. Even if staff are fully immunized, all bets are off if an undiagnosed case of measles gets into a healthcare facility.
-
Healthcare Workers, CDC at Odds Over COVID Precautions
Inundated with criticism from healthcare workers, highly vulnerable patients, and those with long COVID, advisors to the CDC must make a Solomonic decision. At a time when the CDC is trying to simplify and normalize community precautions for SARS-CoV-2, initial efforts to do so in the hospital have backfired spectacularly.